The present invention relates to compounds of formula (I) wherein G1 to G8 are as defined herein. The compounds are PK inhibitors and as such represent a new approach to treating pathogenic infections, including multidrug resistant pathogens. Disclosed herein are the compounds of formula (I), pharmaceutical compositions comprising the compounds of formula (I) and their use in the treatment of antimicrobial infection. (Formula (1))
本发明涉及式(I)的化合物,其中G1至G8如本文所定义。这些化合物是PK
抑制剂,因此代表了治疗病原体感染的新方法,包括多药耐药病原体。本文披露了式(I)的化合物,包括含有式(I)的药物组合物以及它们在抗微
生物感染治疗中的应用。